Toll Free: 1-888-928-9744

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020

Published: May 4, 2016 | Pages: 565 | Publisher: Axis Research Mind | Industry: Biotechnology | Report Format: Electronic (PDF)

Global Market Watch:

Primarily supported by ownership types; Private Biobanks and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to witness a value of US$37.1 billion by 2020. Geographical analysis for Private Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the analysis period 2014-2020. North America is not way behind with a CAGR of 9.95% followed by Europe at 9.56% respectively.

Report Focus:

The report “Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking ownership market. Further, the subdivided categories include:

- Private Banks
a. Disease-Based Banks
b. Population-Based Banks
c. Academics
- Public Banks1
a. Disease-Based Banks
b. Population-Based Banks
c. Academics
- Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics, Transplantation and Biobank Storage Companies
- Newborns, Adults or Pregnant Women
- Medical Institutions, Research and Forensics

The period considered for the human biobanking ownership market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1270 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

List of Key Companies

North America

- Vericel Corporation
- Acorda Therapeutics, Inc.
- Alpha Cord, Inc.
- Affymetrix, Inc.
- Cellerant Therapeutics, Inc.
- Cryo-Cell International, Inc.
- Mesoblast, Inc.
- Atgc Labs
- Autogen, Inc.
- Barber Nichols
- Beckman Coulter, Inc.
- Biocision
- U.S. Stem Cell, Inc.
- Biolife Solutions, Inc.
- Biological Specimen Inventory System
- Biomatrica, Inc.
- Biostorage, Llc.
- Cti Biopharma Corp.
- Chart Industries, Inc.
- Charter Medical, Ltd.
- Corcell, Inc.
- Cord Blood Registry
- Core Dynamics (Usa), Inc.
- Cryolife, Inc.
- Cryomagnetics, Inc.
- Cryoplus, Inc.
- Cryoxtract
- Custom Biogenic Systems
- Dataworks Development, Inc.
- Dna Genotek, Inc.
- Epl Archieves, Inc.
- Genzyme Corp.
- Gilead Sciences, Inc.
- Hamilton Storage Technologies
- Labvantage Solutions, Inc.
- Labware, Inc.
- Lifenet Health
- Caladrius Biosciences, Inc.
- Eppendorf, Inc.
- Novare Biologistics
- Origen Biomedical, Inc.
- Osiris Therapeutics, Inc.
- Pacific Bio-Material Management, Inc.
- Promeddx, Llc
- Provia Laboratories, Llc
- Qiagen Nv
- Rand Corporation
- Ruro
- Seracare Life Sciences
- Scientific Instruments, Inc.
- Sp Scientific
- Spectrocell, Inc.
- Abbott Laboratories
- Steelgate, Inc.
- Trillium Therapeutics, Inc.
- Stem Cells, Inc.
- Stemcell Technologies, Inc.
- Lifeline® Cell Technology
- Thermo Fisher Scientific, Inc.
- Cesca Therapeutics, Inc.
- Trans-Hit Biomarkers, Inc.
- Vaisala, Inc.
- Viacord
- Vital Therapies, Inc.
- Wheaton Science Products, Inc.

Europe

- Panasonic Biomedical Sales Europe B.V
- Epistem Ltd.
- Aqix
- B & C Group
- Bbmri
- Lifegene
- Biobank Ireland Trust
- Biokryo Gmbh
- Biorep Srl P.Iva
- Biostorage Technologies, Inc.
- Boehringer Ingelheim, Gmbh
- Cells4life, Ltd.
- Cryo Bio System
- Cryo-Save, Ag
- Decode Genetics
- Ge Healthcare Life Sciences
- Genesisbps
- Highres Biosolutions
- Indivumed
- Lifegene Biobank
- Lifelines Cohort And Biobank (Lifelines)
- Linde Gas Cryoservices B.V.
- Modul-Bio Sas
- Mts Cryostores Uk Ltd
- Noray Bioinformatics S.L.U.
- Reneuron Group Plc
- Sanofi Aventis
- Soventec Gmbh
- Stirling Cryogenics & Refrigeration Bv
- Tecan
- Tissue Solutions
- UK Stem Cell Bank

Asia-Pacific

- Cole Parmer Instrument, Co.
- Cordlife Pte., Ltd.
- Cryocord Sdn.Bhd.
- Cryologic Pty. Ltd.
- Genesearch
- Ocimum Biosolutions
- Reliance Life Sciences
- China Cord Blood Corporation

Rest of World

- Babycell Egypt
- Gamida Cell Ltd.

 

Table of Contents

I. Report Focus

A. Introduction
Biorepository
Classifying Biobanks
Storing Samples In A Biobank
Biospecimen Security And Storage

The Generational Evolution Of Biobank

Putting Together A Bio Bank With Its Requirements And Capacities
Technical Requirements
Functional Requirements

Biorepository Operations
Getting A Biorepository Accredited
The Role Of Synthetic Data In Biobank Analysis

B. Biobanking Benefits
Conclusion

C. Biospecimens (Collection, Processing, Storage, Retrieval And Disseminate) Biospecimens In Cancer Research

Biospecimens - The Legacy Plan
Decades Old Specimens May Be Today’s Research Treasures

Biospecimen Management System
The Modern Approach To Biobanking
Isolating Stomach-Cell Populations Using Lcm
Results From The Bpv Program
Evaluation Of Pre-Analytical Factors On Identification 
Of Copy Number Variations
The Impact Of Ex-Vivo Ischemia Time On Quality Of Rna
The Ideal Physical Environment For Biospecimens
Case Study: Advanced It System For Research Biorepository
Physical Phenomenon At Low Temperatures
Biological Phenomenon At Low Temperatures
Storage Methods For Various Biospecimens
1. Storing Proteins And Purified Nucleic Acids
2. Storing Cryo-Preserved Cells
3. Storing Tissues

Conclusion

Transporting Biospecimens

Effects Of Transportation On Mononuclear Cells
Finding Bio-Samples
Out Of The Cold-Dry State
Banking On Success For Precision Medicine
The Close Of The Ultimate Period In Bio-Banking
Cost Of Value Study: Relate The Theory To Biobanks

Malfunction Costs:

External Stoppage Costs:
Biobank Economic Modeling Tool: A Cost Improvement Device For Continuity Of Bio-Banks
Institution Of An Iso15189 Accredited Bio-Bank For Global Clinical Research Studies
Critical Moves To Build Bio-Banks: Stage Wise Process For Low Income Nations
The Institution Of A Bio-Bank And Cohort Network (Bcnet) For Low And Middle Income Countries
Bio-Banking And Translational Medicine: The Scholarly Outlook
A Workable Methodology Devised By Bio-Bank Graz: A Representation For Other University-Based Institutions
The Sustainability Issue Of A Community Hospital-Based Bio-Bank And Core Molecular Laboratory: The Beaumont Understanding
To Maintain A Disease Centered Bio-Banking - An Active Approach

D. Biobanking Principles
Norms Based On Interface Comprehension
Data Standards Are Not Maximized In Research Bio-Banking
Data Standards - Proposed By Obbr And Isber
Data Standards Program For Bio-Banks
Design Of A Registry Of Standard Operating Protocols For Tissue Compilation

E. Path Breaking Technologies
The Bio-Bank Information Management System Life Cycle Organization And The Bims Cloud Management Platform
Amalgamation Of Standard Pre-Analytical Code With Bio-Bank Organization Software Freezer Pro
Evaluation Of Computerization Technologies And Physical Storage And Recovery
Future Outlook And Concerns In The Setup Of Software Solutions In An Interdisciplinary Clinical Biobank
A Mechanical Laboratory Workflow For Stool Dna Removal
Consistent Workflow For Bio-Material Appeals
Partially Computerized Bio-Bank Sample Processing With A 384 High Density Sample Tube Robot Deployed In Cancer And Cardiovascular Research
An Autonomous Appraisal Of The Cryoxtract Cxt350 Frozen Bio-Specimen Coring Application With Tissue And Stool Fecal Samples
Heat Standardization Of Tissue Samples Supports Measurement Without Intrusion From Post-Mortem Occurrences And Permits For Refinement Because Of Minimized Intra Group Variability
Biot Cryocarrier - Standardized Cryogenic Temperature Handling Of Biospecimens
Protection By Vaporization For Bio-Banking
Optimum Specimen Security With Complete Automation Characteristics: The Automated Ln2 Vapour Phase Freezer
Exercise Of Electronic P-Chips In A Mono And Duotagging System For Sample Tubes Used In Bio-Banking
Sample Trail And Prerequisite With Iplex® Pro Sample Id
Usage Of An E-Consent System For Bio-Bank Patient Consent – The Three Whys
Cell Line Verification With The Use Of Snp Trace™ Panel: A High-Throughput, Affordable Snpbased Interface For Fingerprinting, Identifying Infectivity, And Establish Origin Of Derivative Cell Lines
Next-Generation Dna Sequencing With Sustained Preserved Serum Samples
An Assessment Of Frozen Aliquotting Application For The Stabilization Of Small Molecule And Peptides In Bio-Analytical Technology

F. Biobanking Performances
Performances Inside The Bio-Bank
Ethical, Legal And Appropriate Strategies
Societal Commitment For Growth Of Cdc Policy Leading Supervision Of Specimens Attained From American Indian/Alaska Native People
Legal And Regulatory Hurdles That Impact Completion Of An Inter-Institutional Bio-Bank System
In –Depth Appraisal On Bio-Banking Performances
Specimen Research
Safeguard And Control Sample Data
Bio-Samples Preservation And Safety Precautions
Monitor Samples Through Transport
Farm Out Samples
Conclusion

G. Biobank Ownership

Private Banks
Public-Private Partnership In Bio-Banking

Public Banks
Cost Recovery For A Public Biobank – Introduction
Biobanks: Associated Costs
Modern Developments In Biobank Principles

H. Human Biobanking Ownership - Geography Market Briefing

North America
Europe
Asia-Pacific
Rest Of World

I. Private Biobanks - Geography Market Briefing
North America
Europe
Asia-Pacific
Rest Of World

J. Public Biobanks - Geography Market Briefing
North America
Europe
Asia-Pacific
Rest Of World

II. Market Analysis

Human Biobanking Ownership – Industry Snapshot
A. Human Biobanking - Ownership - Segmentation

Human Biobanking Ownership - Global
Human Biobanking Ownership - By Geography
North America
Europe
Asia-Pacific
Rest Of World

Human Biobanking - By Ownership Type
Human Biobanking Ownership - Type - By Geography
Private Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Private Biobanks - By Type
Private Biobanks – Type – By Geography
Disease-Based Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Population-Based Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Biobank Academics
North America
Europe
Asia-Pacific
Rest Of World

Public Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Public Biobanks - By Type
Public Biobanks – Type – By Geography
Disease-Based Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Population-Based Biobanks
North America
Europe
Asia-Pacific
Rest Of World

Biobank Academics
North America
Europe
Asia-Pacific
Rest Of World

B. Growth Rate Analysis
Global Human Biobanking Ownership - Market Growth Rates

Human Biobanking Ownership Market - Type
Global Human Biobanking Ownership – Type Growth Rates

Private Banks Market - Type
Global Private Banks - Type - Growth Rates

Public Banks Market - Type
Global Public Banks - Type - Growth Rates

C. Investment Focus

III. Industry Overview

A. Biobanking - Geographical Distribution In Detail

Biobanking In The Americas

Canada
To Assess The Scale And Limitations Of Industry Access To Publicly-Financed Biobanks In Canada
The Canadian Longitudinal Study On Aging: Biorepository Functions And Networks

Brazil
Outcomes To Give To Contributors: A Debate In Brazil

USA
Status On The Development And Growth Of A Combined System Of Repositories At The University Of Iowa

Biobanking In Europe
Consolidation On Present Advantages
European Biobanks Are Crucial Resources Assets For The Distribution Of Individualized Medicine
Cohorts As A Potential Instrument To Know Personalized Distinction
Ethical, Legal And Social Issues (Elsi)
Priority Issues For Personalized Medicine Within Europe
Biobanking And Biomolecular Resources Investigate Communications - European Research Infrastructure Consortium
Future Entry In To Bigger European Cohorts Via Transnational Biobanking Infrastructure Bbmri-Lpc
9 Years Relating Swiss Biobanks – En Route To A Swiss Biobanking Policy

Germany
Constant And Maintainance And Support Of Biobank-Based Medical Research: A Decade Of Experience In Germany

Austria

United Kingdom
Combined Effective Network Of Biobanks

Italy
Biobanks And Ethical Concerns In Italy

Other European Countries
Strategy Development For Emerging Biobanks On The Example Of Kosovo And Albania

Biobanking In Asia-Pacific

Japan
Evaluation Of Id Integrity With Abo Blood Typing-Questionnaire To Genomic Data In Japanese Biobank
Assessment Of Cell-Type Composition In Peripheral Blood Mononuclear Cells Enhances Value Of Omics Data In Biobank Research

South Korea
Current Trends In Korea Gynecologic Cancer Bank
Ebiobanking System For Korea Gynecologic Cancer Bank

China
Achievements
Biobanking For The Born In Guangzhou Cohort Study: An Innovative Resource For Maternal And Child Health Research In China

Aims

Advantages
Construction Of Shanghai Cancer Biobank Stage For Research

India
Objectives
Goals 
Areas 
Principles
The Age Bio-Banking In India
To Create A Disease-Linked Reliable Biobank In India
Moral Concerns In Biobanking: Stepping Up The Program In India
Biobanking Is A Promising Proposition In India-Factors

I. Ethical Concerns With Regard To Biobanking
People’s Perspective Towards Biobanking Research
Acceptance By Contributors In Biobanking Research

Consent Types
Removal Of Consent/Obliteration Of Bio-Samples
Chief Causes For Pull Out

Privacy And Secrecy

II. Ethical Issues Linked To Research Procedures

Storage Of Samples
Derived Or Extensive Uses Of Stored Samples
Relocation Of Samples And Information

III. Conclusion
First Biobank By 2016 In Eastern India

Australia
Australian Prostate Cancer Bio-Resource, 2015
Enhancing Bio-Samples Quality Inside The Banking System: An Australian Outlook

Biobanking In Rest Of World
The Consequences Of Mini-Biobank In Hazardous Climates In Iraq
Biodiversity/Environmental Microbial Storehouse System In Emerging Nations-Spotlight On Nigeria
The Progress Of The National Biobanking Industry For Preservation Of South African Biodiversity
Qatar Biobank: Public Health Concerns Reported
Biobanking Initiative In Saudi Arabia: The Cegmr Biobank Know-How

B. A Review On Bio “Banks”
Relevance Of Biobanks In Scientific Research

C. Major Prospects For Biorepositories In The Future
The Key Impact Of Biorepositories In Its Applications

Biggest Challenges And Opportunities In Biorepositories
Biobanks Will Be Challenged By Increasing Financial Pressures
Biggest Opportunities
Present Challenges Of Biobanking: Bioethical And Property Issues
Added Value Of Biobanks For Health: An Evolutionary Perspective

Future Challenges

Conclusions

D. Industry Activities
Mergers/Acquisitions/Agreements/Patents Grants/Joint Ventures/Innovations/Product Launches/Etc……
Cesca Therapeutics Enters Into Collaborative Agreement With Center For Immune Cell Therapies At Memorial Sloan Kettering Cancer Center
Agilent Technologies To Acquire Seahorse Bioscience, Industry Leader In Tools For Measuring Cell Metabolism
International Stem Cell Corporation Announces Next Phase Of Research Collaboration With Rohto Pharmaceutical Co., Ltd. Of Japan
Partners Get $12.3m To Advance Genomic Medicine
New Study Demonstrates Absence Of Extractable Organic Contaminants In Micronic’s Polypropylene Sample Storage Tubes
Valeant Pharmaceuticals To Acquire Synergetics Usa
Sysmex Receives In-Vitro Diagnostic Approval For Manufacturing And Sales Of Three Platelet Aggregation Agonist Reagent Kits
Amag Pharmaceuticals Completes Acquisition Of Cord Blood Registry
Biotek Synergy™ Neo2 Granted Cisbio Htrf® Certification
Avita Medical Announces New Research Partnership With University Of Huddersfield
Stemcell Technologies Inc. Enters A Licensing Agreement With Ips Academia Japan, Inc. For Induced Pluripotent Stem Cell Research Technologies
Immatics And Md Anderson Announce Launch Of Immatics Us, Inc., To Develop Multiple T-Cell And Tcr-Based Adoptive Cellular Therapies
Bio-Rad Introduces The Ih-500, A Fully Automated Random Access System For Blood Typing And Screening
Groundbreaking Clinical Trial To Assess Use Of Newborn Stem Cells In The Treatment Of Pediatric Stroke
Genotyping Begins On Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm And Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
Stem Cells - Promising Options For Alternative Medical Therapeutic Approaches
Celgene Handed $1 Billion To Small Biotech Developer Juno Therapeutics
Medimmune Partners With The University Of Sheffield To Generate Innovations In Cell Factory Engineering Science
Cytox And Affymetrix Form Strategic Partnership To Develop And Commercialize Blood-Based Genetic Assay For Alzheimer’s Disease Risk Assessment
Genotyping Begins On Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm, And Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
Mount Sinai Medical Center Selects Stemsoft Clinic 
Integra Lifesciences Completes Acquisition Of Tei Biosciences And Tei Medical
Bloodcenter Launches Gene Deletion/Duplication Analysis
Cryoport Provides Cryogenic Logistics Solutions To Hemacare Corporation
Biomatrica, Inc. Announces Release Of Dnagard® Saliva Ht, Saliva Dna Collection
Seracare Life Sciences Announces Strategic Partnership With Vivebio To Enable
Lake Shore Exhibiting Cryogenic Monitoring And Control Solutions At Cec/Icmc
Cryolife Receives Expanded Indication For Bioglue® In Japan
Dna Genotek Inc. Receives Ce-Ivd Mark For Its Omnigene®•Gut Microbiome Collection Kit
Debiopharm International Sa Acquires Fibrotrap Sample Processing Technology From Spinomix
Sysmex And Labcorp Announce A Strategic Collaboration For Blood-Based Molecular Testing Services And Products To Support The Development Of Precision Medicine In Oncology
Reneuron Group Plc S Research Collaboration With Benitec Biopharma
Stemcell Technologies Launches Innovative Products To Support Car T Cell Research
Ultra Low Binding Tubes For Proteomics
Caladrius Biosciences, Inc. Finalizes Corporate Name Change From Neostem, Inc.
Stemgent, A Reprocell Group Company Launches A New High Performance Self-Replicative Rna Reprogramming Kit
Takara Bio Europe Releases An Innovative Ips Cell Culture Medium For Pre-Clinical Use: Cellartis® Def-Cs™ Xeno-Free Culture Medium Göteborg, Sweden
Octane And Lonza Announce Exclusive Collaboration To Evaluate Groundbreaking Autologous Cell Therapy Technology
Axt To Distribute Openspecimen Biobanking Software Solution
Nikon And Lonza Form Collaboration For Cell And Gene Therapy Manufacturing In Japan
Dna Genotek Inc. Launches Microbial Dna Self-Collection Kit-Omnigene®•Gut Product Optimizes Samples For Microbiome Analysis
Biocision And Brooks Automation Announce Industry's First Portable Cryogenic Biospecimen Transport System With Integrated Real-Time Temperature Monitoring
Cryo-Cell’s New Cord Blood Processing Method Enables Parents To Obtain Better Cord Blood Units For Their Babies
Avita Medical Announces Issuance Of A New U.S. Patent For Recell®
Titian Software Expands Offering With New Mosaic Freezer Management
Alliqua Biomedical Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
Secure Automated Cryogenic Storage
Lonza, The World’s Leading Developer And Manufacturer Of Cells For Regenerative Medicine Therapeutics, And Nikon Corporation Announced Today An Exclusive Collaboration In The Field Of Cell And Gene Therapy Manufacturing In Japan. 
Neostem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma 
Combimatrix Launches Buccal Swab Dna Collection As Alternative To Blood Draws For Postnatal Genetic Testing
New Ultra-Low Temperature Freezer Offers Outstanding Sustainability And Sample Protection
Neostem, Inc And Allcells, Llc To Collaborate With Mount Sinai As Part Of $8.8 Million Grant To Further Stem Cell Research
Sysmex Inostics Announces Agreement With Indivutest To Offer Blood Based Mutation Testing
Celgene To Acquire Quanticel Pharmaceuticals
Cord Blood Registry® Uses Biolife Solutions Cryostor® Clinical Grade Freeze Media In The Storage Of Umbilical Cord Tissue Stem Cells
Florida Hospital Cancer Institute Selects Stemsoft Clinic
Genmab Achieves Usd 10 Million Milestones In Daratumumab Collaboration With Janssen
Alvetex® 3d Cell Culture Platform Reaches New Heights With Project Aboard The International Space Station (Iss).
Lonza Introduces Cytosmart™ System For Walk-Away Live Cell Imaging
Brooks Automation Introduces Biostore Iii Cryo Automated Cryogenic Sample Management System
Biocision And Brooks Joint Development Partnership To Unveil New Cryogenic Sample Handling And Transport Product
Paml And Bloodworks Nw Sign Letter Of Intent To Collaborate On Innovation
Brooks Automation Introduces Biostore Iii Cryo Automated Cryogenic Sample Management System
Biotime’s Clinical Grade Stem Cells From Subsidiary Es Cell International To Be Used In Planned Cirm-Funded Preclinical Studies Of Huntington’s Disease
Biotime Licenses Beckman Research Institute Of City Of Hope To Manufacture Clinical Grade Stem Cells
Blood Center Affiliation Unveils New Name, Expanded Offerings To Healthcare Systems
Lonza Introduces Cytosmart™ System For Walk-Away Live Cell Imaging
Fujifilm Holdings To Acquire Cellular Dynamics International, Inc.
Genvec And Therabiologics Form Collaboration To Develop Neural Stem Cell Mediated Cancer Therapies
Cryo-Cell International, Inc., Cord Blood Banking Leader, Takes Significant Ownership Stake In Cord Blood America, Inc., And Encourages Cbai Shareholders To Vote Against Upcoming Share Authorization Proposal
Combimatrix Selects Cryoport As Logistics Partner For The Distribution Of Its New Genetic Screening Service
Bluechiip Tracking Solutions Executing Strategic Priorities In Biobanking
Cordlife Partners With Leading Neurologist On   Study In Child Autism Using Own Cord Blood Stem Cells
Leica Em Cryo Clem Features The World’s First Cryo Clem Objective
Partnership With Live Cell Imaging Company
Astrazeneca To Collaborate With The Harvard Stem Cell Institute In Diabetes
Handheld Wireless 1d / 2d Code Reader
Biolife Solutions Cryostor® Cell Freeze Media Used In Mayo Clinic Safety And Feasibility Study Of Umbilical Cord Blood-Derived Cells For Pediatric Cardiac Regeneration
Expiration Of The Option Of Teva Under The License Agreement With Cellcure Neurosciences
University Of Illinois At Chicago Selects Stemsoft Clinic
Esperite Pioneers First Treatment Worldwide Of Cerebral Palsy Using Two Types Of Stem Cells
Greiner Bio-One Presents Innovative Cryo’s Biobanking Tubes
Esi Bio – A Division Of Biotime, Inc., Announces Alliance Agreement With Pivotal Scientific Ltd For Distribution Of Stem Cell Products
Puget Sound Blood Center Is Now Bloodworks Northwest 
Labcorp Completes Acquisition Of Covance
Biolife Solutions Launches New Cell Thawing Media Products In Response To Worldwide Shortage Of Dextran Solutions
Tigenix And Lonza Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas In Crohn’s Disease
Epistem Announces The Successful Evaluation Of New Rna-Amp™ (Rna-Amplification) Technology
Stemgent, A Reprocell Group Company And Transposagen Biopharmaceuticals Enter Into A Service Partnership Agreement Providing Genetically Engineered Stem Cells
Tigenix And Lonza Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas In Crohn’s Disease
International Stem Cell Corporation Announces Completion Of Cell Bank For Parkinson's Disease Clinical Trial
Cellular Dynamics Manufactures Cgmp Hla “Superdonor” Stem Cell Lines To Enable Cell Therapy With Genetic Matching
Vitro Biopharma Announces Advances In Clinical Application Of Stem Cell Therapy For Neurological Conditions
New Healthy Ageing Biobank Milestone
Alliqua Biomedical, Inc. To Acquire Celleration, Inc.
Agilent Technologies Introduces Oneseq To Streamline Cytogenetic Research
Cancercare Manitoba Selects Stemsoft Lab
Alliqua Biomedical Announces Group Purchasing Agreement With Premier, Inc.
Valeant And Astrazeneca To Partner On Brodalumab
Harvard Bioscience Acquires All Operations Of Heka Electronik
Brooks Automation Announces Collaboration Agreement With Chart Industries
Avita Medical Announces First Patient Enrollment In Us Pivotal Study Of Recell® For The Treatment Of Burns
Neostem Receives Drug Manufacture License For Irvine Facility
Neostem And Invetech Announce Agreement To Develop Closed Processing System For Cell Therapy Manufacturing
Cord Blood Registry And Cellular Dynamics International Announce Collaboration To Reprogram Newborn Stem Cells Into Induced Pluripotent Stem Cells
Cord Blood Registry And China Cord Blood Corporation Enter Into Strategic Collaboration
China Cord Blood Corporation And Cord Blood Registry Enter Into Strategic Collaboration
Essential Pharmaceuticals Provides Solutions To Keep Cells And Organs Healthy
Apollo Health And Lifestyle Ltd. Expands Its Footprint With The Acquisition Of Nova Specialty Hospitals
Brooks Automation Announces Collaboration Agreement With Chart
Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing
Symphogen A/S Licenses The Selexis Suretechnology Expression Platform And Cell Line
Nyscf And The Cmta Enter Collaboration To Advance Neuropathies Research
Leica Biosystems And Mayo Clinic Collaborate On Future Of Cytogenetics Imaging
Biotime Subsidiary Es Cell International And Ge Healthcare Cross-License Patents In The Field Of Cell Assays For Drug Testing
Takara Bio Inc. Will Take Over The Supply Of Sc Proven Products Formerly Supplied By Stem Cells Sciences
Mr Solutions Announces The First Installations Of Its Second Generation Cryogen Free Magnet Technology For Increased Scientific Capabilities In Preclinical Mri
Geron Announces Early Hsr Clearance For Global Strategic Collaboration With Janssen
Cryofab Inc. (Nj) Acquisition Of Leading Cryogenic Valves Suppliers Cryocomp Inc. (Ca)
Novadaq Appointed Exclusive Worldwide Distributor Of Lifenet Health’s Dermacell Tissue Products
Toshiba Corporation Selects Affymetrix Axiom Platform For Its Newly Launched Genotyping Service In Japan
Bloodcenter To Form Strategic Alliance With Indiana Blood Center 
Cytomedix Announces Corporate Name Change To Nuo Therapeutics, Inc.
Irvine Scientific Introduces Dmso-Free, Chemically-Defined Cryopreservation Solution For Mesenchymal Stem Cells
Bluechiip Signs International Agreement For Technology Integration
Sigma-Aldrich Completes Acquisition Of Cell Marque
Cellular Dynamics And Northwestern University Take First Steps Toward Rebuilding An Organ Using Manufactured Human Cells
Baker Ruskinn Brand Promises New Tools For Cell Science
Lifecell Corporation And Novadaq Technologies Agree To Early Transition Of Spy Elite® Intraoperativeperfusion Assessment System Business Back To Novadaq.
Affymetrix Exclusively Licenses Technology From Peptide Groove Llp For Hla Typing From Genotyping Data
Alliqua Biomedical Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
New Blast Freezers Offer Rapid Freezing For Short And Long Term Cold Storage
New Innovations Advance Upstream And Downstream Bioprocessing For Biopharmaceutical Manufacturers
Osiris And Arthrex Announce An Exclusive Partnership For The Commercialization And Development Of Cartiform®
Baker Introduces Cultivo™ Co2 Incubator
Baker Ruskinn Brand Promises New Tools For Cell Science
Brooks Automation Acquires Fluidx, A Leading Provider Of Consumables And Instruments Used For Biological Sample Storage
Roslin Cells Working With Tokyo Electron On Developing New Smart Cell Processing Technologies
Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank 
Roosterbio Selects Biolife Solutions Cryostor® To Commercialize Human Bone Marrow-Derived Stem Cells
Reprocell Acquires The Ips Cell Business Unit Of Stemgent, Inc.
Brainstorm Granted European Patent Covering Its Stem Cells For The Treatment Of Cns Diseases
Biolife Solutions Forms Biologistex Ccmsm Joint Venture With Savsu® Technologies To Market Intelligent, Controlled Temperature Containers For Biologics
Failure To Invest In Biobank ‘May Jeopardise Storage Of Vital Tissue Samples
Labcorp Announces Agreement To Acquire Liposcience
Irvine Scientific Introduces Serum-Free Differentiation Media To Its Cell Therapy Product Line
Cryomagnetics Acquires R & D Tectonics
Stem Cell Company Reprocell (Japan) Acquires 3d Cell Culture Company Reinnervate Ltd (Uk) And Human Tissue Supplier Bioserve (Usa)
Fda Clears Mayo Clinic For Manufacture Of Nurown And Participation In Brainstorm’s Phase 2 Als Trial
Vistagen Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform
Beckman Coulter Diagnostics And Copan Announce Expansion Of Distribution Agreement For Automated Sample Processing Systems And Digital Microbiology
Biovision Introduces Industry's Most Simplified Cetp And Pltp Activity Assay Kits
New Highly Sensitive Test To Screen Donors Of Blood, Tissues, And Organs For Hepatitis E Virus Receives Ce Mark
Essential Pharmaceuticals Announces The Release Of Cell-Ess® Serum Replacement For Cell Culture
Cellular Dynamics Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples
China Cord Blood Corporation And Cordlife Group Limitedannounce Collaboration To Aid Asia-Based Patientswith Cord Blood Stem Cell Therapy 
The Tecan Group (Six Swiss Exchange: Tecn) Today Announced The Acquisition Of Ibl International
International Stem Cell Corporation Signs Agreement Including Certain Terms For A Definitive License Agreement With Rohto Pharmaceutical Co., Ltd. Of Japan
Combimatrix Signs Contract With Stratose
Cordlife Group Limited And China Cord Blood Corporation Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy
Lane Blood Center And Psbc Confirm Affiliation
Precious Cells Biobank Acquires Stem Cell Technology Leader Pharmacells Group
Biolife Solutions Announces Manufacturing Agreement With Somahlution Llc
Geisinger And Indivumed Partner For Personalized Medicine Initiative In The Usa
Rutgers’ Human Genetics Institute Lab Expands Into Clinical Testing
Cord Blood America, Inc. Announces Mesenchymal Stem Cell Expanded Tissue Service Offering Positions Company To Participate In One Of The Fastest Growing Areas Of Stem Cell Research
Tecan Unveils New Fluent™ Laboratory Automation Solutions
Atcc Teams With Cdc And Thermo Fisher Scientific On Public Health Rt-Pcr Assay
Beaumont, Botsford, Oakwood Reach Definitive Agreement To Create New, Not-For-Profit Health Organization
Partner With Flow Cytometers Analyzers Company
Cell Therapeutics, Inc. Announces Change Of Name To Cti Biopharma Corp. Seattle
Cryoxtract Announces Integration Of Cxt750 System Into France's National Institute For Agricultural Research For Use In Important Human Gut Microbiome Research
Cryoxtract Enters Into Distribution Agreements With Cambridge Bioscience Ltd. And Lbd Life Sciences Ltd.
Alliqua Acquires Choice Therapeutics
Cellcentric Receives Patent Grants For Gene Demethylation Technology
Partner With Time-Lapse Cytometers Company
Cellular Dynamics Announces Launch Of Icell(R) Dopaneurons, Neural Floor Plate-Derived Midbrain Dopaminergic Neurons
Brooks Automation, The University Of Oxford And Uk Biocentre Announce Purchase Of Multiple Brooks Automated Sample Management Systems
Roslin Cells To Manufacture Blood Cultured From Stem Cells
Neostem Announces Definitive Agreement To Acquire California Stem Cell, Inc.
Atcc Expands Its Portfolio Of Certified Reference Materials To Include Quantitative Mycoplasma Dna
Alliqua Biomedical, Inc. To Acquire Celleration, Inc.
Lonza And Biowa Sign Potelligent® Chok1sv Cell Line Technology Licensing Agreement With Argen-X
Combimatrix Announces Partnership With American Pathology Partners To Provide Products Of Conception Testing
Takara Bio Obtains A Governmental Grant For Commercialization Of Its Tcr Gene Therapy Projects
Brainstorm Granted Key Us Patent For Its Autologous Stem Cell Technology
Lonza And Biowa Sign Potelligent® Chok1sv Cell Line Technology Licensing Agreement With Argen-X
Modular Vertical Freezer Rack For Biobanking Launched By Micronic
Greiner Bio-One Presents Innovative Cryo.S Biobanking Tubes
Thermo Fisher Scientific Completes Acquisition Of Life Technologies Corporation
Biopta Announces Launch Of Industry’s First Catalogue Of In Vitro Human Tissue Assays
Thermo Fisher Scientific Reaches Agreement To Sell Its Cell Culture, Gene Modulation And Magnetic Beads Businesses To Ge Healthcare
Biomatrica And Sigma-Aldrich Sign Distribution Agreement
Athersys Announces New Patents In Japan For Stem Cell And Regenerative Medicine Technology
Cell Therapy's Heart Tissue Regeneration Hope
Cellular Dynamics Signs Agreement With Nestle Institute Of Health Sciences To Supply Icell® And Mycell® Products For Nutritional Research
Lifecell Corporation Acquires Advanced Adipose Tissue Injector
Combimatrix Announces Contract With Galaxy Health Network
Combimatrix Announces Partnership With Propath To Provide Products Of Conception Testing
Stemsoft Software Inc. And Jaf Consulting, Inc. Announce Collaborative Partnership
Thermo Fisher Scientific Reaches Agreement To Sell Its Cell Culture, Gene Modulation And Magnetic Beads Businesses To Ge Healthcare
New Dmso-Resistant 1536 Well Storage Plate
Bmg Labtech And Invivosciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery In Engineered 3d Tissues
Low Profile Screw Caps Designed In Conjunction With The Hannover Unified Biobank Launched By Micronic
Queensland Node Of Apcb Gain Access To Unique Samples
Thermo Fisher Scientific Brings Several Innovations In Bioprocessing Technologies And Systems

E. Market Trends
Groundbreaking Technology Collaboration To Optimize Medical Research
First 300 Cell Lines To Support Autism, Heart, Liver, Lung And Eye Disease Research
Towards ‘Engagement 2.0’: Insights From A Study Of Dynamic Consent With Biobank Participants
Finding Biomarkers For Early Lung Cancer Diagnosis
Biobanking Viable Immune Cells - Transportation Matters!
Cancer Biobank Informs Future Treatment
World’s First T Cell-Qualified Serum Replacement Now Available
Biobanking: A Vital Asset For Belgium Scientific Excellence 
Plasma Biobanking: Maximizing Patient Samples
Bridging ‘Biobanking’ And Biomedical Research Across Europe And Africa: ‘B3africa’ Launched In Cape Town
Finding The Best Way To Process Gut Microbiome Samples
Innovation In Biobanking: Pushing The Boundaries
New Research Tool Tracks Real-Time Dna-Protein Binding In Cells
Seoulin Bioscience To Distribute Cellular Dynamics’ Products In Korea
Cryogenic Storage Solution Available In Europe
A Next-Gen Biobank That’s Based On The Cloud
Health Research Group Makes Recommendations On Eu Data Protection Reforms
Genotyping Begins On Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm, And Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
Reg-Galapagos Licenses Organoid Technology From The Hub Foundation For Use In Cystic Fibrosis And Ibd Research
Ccfa Launches Development Of World’s Largest Research Database For Crohn’s Disease And Ulcerative Colitis
The Joint Venture Of Synovial Tissue Cryopreservation
Antifreeze Polymer Protects Cells As They Thaw
Australia’s First Comprehensive Skin Cancer Tissue Bank
Awareness Of The Procure Biobank
Biosamples And Cryopreservation: What Tube Should I Use?
Ibbl Teaches The Ins And Outs Of Biobanking
Nhlbi Next Gen Consortium Partners With Wicell To Distribute Over 1,500 Well-Characterized, Novel Cell Lines For Use In Disease Research
Automated Pbmc Isolation For Biobanking With Tecan’s Freedom Evo®
Biotek Expands In The United Kingdom
Ecacc And Ds Pharma – 10 Years Supporting Cell Culture Science In Japan
Dried Blood Spots: New Applications For Biobanking?
Multicare, Bloodworks Nw Expand South Sound Cord Blood Collection
New Ultra-Low Temperature Freezer Offers Outstanding Sustainability And Sample Protection
Biobanking For Global Prostate Cancer Research Collaboration
The Uk Has Joined The Biobanking And Biomolecular Resources Research Infrastructure - European Research Infrastructure Consortium (Bbmr-Eric) At Its General Assembly
Biobanking Collaboration For Lung Cancer Research
Long-Term Biobanking: How Long Can You Hold Samples?
Controlling Sample Exposure To Temperature Variability
Thl Obtained Permission To Transfer Old Sample Collections To Thl Biobank
Choosing Collection Kits Versus Bulk Supplies
Future Of Biobanking And Translational Research In China
Uw To Sell Patient Tissue Samples To Support Research
Msc From Cord Tissue Used To Treat Graft-Versus-Host Disease
First Patient Successfully Transplanted With Cryopreserved (Frozen) Nicord® In Gamida Cell’s Ongoing Phase I/Ii Clinical Trial For Blood Cancers
Store For 20 Million Bio-Samples Opens In Milton Keynes
Pass The Tissue: Ua Creates Bio Repository To Share With Competing Universities
Cold Storage: Deep-Freeze Unit Is Vital To Oklahoma Medical Research Foundation's Work
New European Storage Bank For Stem Cell Studies Coming To Babraham Research Campus
Stem Cells: First Therapy Approved By Eu
National Biobank Symposium Strengthens Cooperation In The Biobank Research
From Dried Cod To Tissue Sample Preservation
Hematologic Cancers: Umbilical Cord Transplantation
New Method To Multiply Stem Cells Makes Cord Blood Even More Valuable
Bioheart Announces Partnership In Colombia
Survey Of Biobanks 2014 In Australia
Biobanks Cooperation Will Bring Opportunities To The Individual Treatment Of Patients Published
Luxembourg’s Biobank Collaborates With Us National Cancer Institute
Ibbl Is Central Biobank For A New European Cancer Research Programme
Cord Blood Cure For Autism
Research That Explores The Use Of Umbilical Cord Blood Cells
New Distribution Partner For Biotissue In Germany, Austria And Switzerland
Research That Explores The Use Of Umbilical Cord Blood Cells
Two New Chordoma Cell Lines Developed, Heading To Repository
Valley Medical Center And Psbc Partner In Cord Blood Program
Could Premature Babies Benefit From Their Own Cord Blood Stem Cells
Nci Biobank Survey
Thl Biobank In Finland Receives License To Operate
Familycord Introduces Familycord Venezuela
Plasticell Signs Deal With Jcr Pharmaceuticals To Use Combicult ® Stem Cell Technology In Japan
Ebisc – The First European Bank For Induced Pluripotent Stem Cells
Successful Release Of Sample To Treat Scid
Wicell Expands Offerings For Researching Human Disease With Cell Lines Designed By Life Technologies For Fluorescent Protein Expression
Biobanking From The Patient Perspective
The Future Of Biobanking
The Challenge: Recruit 500,000 Participants
2015 Eu Data Protection Regulation – Impact On Research Updates
Latest Cryo-Cell International Developments
Cord Blood Stem Cells Can Treat Over 80 Life-Threatening Diseases
Enriching Datasets Through Norwegian Biobank Data From Lifandis As And The Ims Pygargus Methodology

F. Key Company Profiles
North America
Europe
Asia-Pacific
Rest Of World

IV. Industry Company Database

V. Appendix
A. Research Focus
B. About Axis Research Mind
C. Disclaimer
D. Feedback

List of Table

I. Report Focus
1. Compilation Of Studies Describing The Stability Of Specific Biomarkers For Biospecimens (Biofluids, Cells, Tissues) As A Function Of Storage Temperature/Duration
2. Tasks In Biobanking In Brief
3. Models For Collaboration Around Biobanking Costs

H. Human Biobanking Ownership - Geography Market Briefing

North America
4. Human Biobanking Ownership Market - Private Banks And Public Banks For North America Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
5. Human Biobanking Ownership Market - Private Banks And Public Banks - % Of North American Market Value - (2017-2020)

Europe
6. Human Biobanking Ownership Market - Private Banks And Public Banks For Europe Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
7. Human Biobanking Ownership Market - Private Banks And Public Banks - % Of European Market Value - (2017-2020)

Asia-Pacific
8. Human Biobanking Ownership Market - Private Banks And Public Banks For Asia-Pacific Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
9. Human Biobanking Ownership Market - Private Banks And Public Banks - % Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
10. Human Biobanking Ownership Market - Private Banks And Public Banks For Rest Of World Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
11. Human Biobanking Ownership Market - Private Banks And Public Banks - % Of Rest Of World Market Value - (2017-2020)

I. Private Biobanks - Geography Market Briefing

North America
12. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics For North America Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
13. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics - % Of North American Market Value - (2017-2020)

Europe
14. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics For Europe Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
15. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics - % Of European Market Value - (2017-2020)

Asia-Pacific
16. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics For Asia-Pacific Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
17. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics - % Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
18. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics For Rest Of World Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
19. Private Biobanks Market - Disease-Based Banks, Population-Based Banks, Academics - % Of Rest Of World Market Value - (2017-2020)

J. Public Biobanks - Geography Market Briefing

North America
20. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For North America Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
21. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of North American Market Value - (2017-2020)

Europe
22. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For Europe Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
23. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of European Market Value - (2017-2020)

Asia-Pacific
24. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For Asia-Pacific Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
25. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
26. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For Rest Of World Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
27. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of Rest Of World Market Value - (2017-2020)

II. Market Analysis

Human Biobanking Ownership – Industry Snapshot
A. Human Biobanking - Ownership - Segmentation
28. Global Human Biobanking - Segmentation By Ownership

Human Biobanking Ownership - Global
29. Human Biobanking Ownership Market - Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
30. Human Biobanking Ownership Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
31. Human Biobanking Ownership Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

Human Biobanking Ownership - By Geography
North America
32. Human Biobanking Ownership Market - Usa, Canada And Mexico - (2014-2020, In USD$ Million)
33. Human Biobanking Ownership - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
34. Human Biobanking Ownership Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Million)
35. Human Biobanking Ownership Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
36. Human Biobanking Ownership Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Million)
37. Human Biobanking Ownership Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
38. Human Biobanking Ownership Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Latin America - (2014-2020, In USD$ Million)
39. Human Biobanking Ownership Market- % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Latin America Market Value - (2017-2020)

Human Biobanking - By Ownership Type
40. Human Biobanking Ownership Market - Private Banks And Public Banks For Global Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
41. Human Biobanking Ownership Market - Private Banks And Public Banks - % Of Global Market Value - (2017-2020)

Human Biobanking Ownership - Type - By Geography
Private Biobanks
42. Private Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
43. Private Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
44. Private Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Million)
45. Private Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
46. Private Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Million)
47. Private Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
48. Private Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Million)
49. Private Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
50. Private Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Million)
51. Private Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Private Biobanks - By Type
52. Private Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For Global Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
53. Private Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of Global Market Value - (2017-2020)

Private Biobanks – Type – By Geography
Disease-Based Biobanks
54. Disease-Based Private Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
55. Disease-Based Private Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
56. Disease-Based Private Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
57. Disease-Based Private Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
58. Disease-Based Private Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
59. Disease-Based Private Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
60. Disease-Based Private Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
61. Disease-Based Private Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
62. Disease-Based Private Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
63. Disease-Based Private Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Population-Based Biobanks
64. Population-Based Private Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
65. Population-Based Private Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
66. Population-Based Private Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
67. Population-Based Private Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
68. Population-Based Private Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
69. Population-Based Private Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
70. Population-Based Private Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
71. Population-Based Private Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
72. Population-Based Private Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
73. Population-Based Private Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Biobank Academics
74. Private Biobank Academics Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
75. Private Biobank Academics Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
76. Private Biobank Academics Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
77. Private Biobank Academics Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
78. Private Biobank Academics Market - United Kingdom, Germany, France, Spain, Italy, 
The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
79. Private Biobank Academics Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
80. Private Biobank Academics Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
81. Private Biobank Academics Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
82. Private Biobank Academics Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
83. Private Biobank Academics Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Public Biobanks
84. Public Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
85. Public Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
86. Public Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Million)
87. Public Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
88. Public Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Million)
89. Public Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
90. Public Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Million)
91. Public Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
92. Public Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Million)
93. Public Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Public Biobanks - By Type
94. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics For Global Current Trends, Estimates & Forecasts - (2014-2020, In USD$ Million)
95. Public Biobanks Market - Disease-Based Banks, Population-Based Banks And Academics - % Of Global Market Value - (2017-2020)

Public Biobanks – Type – By Geography
Disease-Based Biobanks
96. Disease-Based Public Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
97. Disease-Based Public Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
98. Disease-Based Public Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
99. Disease-Based Public Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
100. Disease-Based Public Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
101. Disease-Based Public Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
102. Disease-Based Public Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
103. Disease-Based Public Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
104. Disease-Based Public Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
105. Disease-Based Public Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Population-Based Biobanks
106. Population-Based Public Biobanks Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
107. Population-Based Public Biobanks Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
108. Population-Based Public Biobanks Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
109. Population-Based Public Biobanks Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
110. Population-Based Public Biobanks Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
111. Population-Based Public Biobanks Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
112. Population-Based Public Biobanks Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
113. Population-Based Public Biobanks Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
114. Population-Based Public Biobanks Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
115. Population-Based Public Biobanks Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

Biobank Academics
116. Public Biobank Academics Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific And Rest Of World - (2014-2020, In USD$ Million)
117. Public Biobank Academics Market - % Of North America, Europe, Asia-Pacific And Rest Of World Market Value - (2017-2020)

North America
118. Public Biobank Academics Market - Usa, Canada And Mexico - (2014-2020, In USD$ Thousand)
119. Public Biobank Academics Market - % Of Usa, Canada And Mexico Market Value - (2017-2020)

Europe
120. Public Biobank Academics Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe - (2014-2020, In USD$ Thousand)
121. Public Biobank Academics Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia And Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
122. Public Biobank Academics Market - China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific - (2014-2020, In USD$ Thousand)
123. Public Biobank Academics Market - % Of China, Japan, India, Australia, South Korea And Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
124. Public Biobank Academics Market - Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa - (2014-2020, In USD$ Thousand)
125. Public Biobank Academics Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America And Rest Of Africa Market Value - (2017-2020)

B. Growth Rate Analysis
126. Human Biobanking Ownership Market - Geographic Region - % Growth Rate Forecasts - (2014-2020)
127. Human Biobanking Ownership - Type - % Growth Rate Forecasts For Private Banks And Public Banks - (2014-2020)
128. Private Banks - Type - % Growth Rate Forecasts For Disease-Based Banks, Population-Based Banks And Academics - (2014-2020)
129. Public Banks - Type - % Growth Rate Forecasts For Disease-Based Banks, Population-Based Banks And Academics - (2014-2020)

C. Investment Focus
130. Human Biobanking Ownership - Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa And India
131. Human Biobanking Ownership - Type - Private Banks And Public Banks- Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa And India
132. Private Banks - Type - Disease-Based Banks, Population-Based Banks And Academics- Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa And India
133. Public Biobanks - Type - Disease-Based Banks, Population-Based Banks And Academics- Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa And India

III. Industry Overview
134. Ccb Invention Of Methods For Data Sourcing Of Biological Samples To All Types Of Biobanks
135. Ccb Invention To Biobanks For Maintaining Minimum Standards
136. Ccb Invention To Biobanks For Best Practice Standards
137. Methods To Link / Delink Data / Samples With Their Identifiers
138. Worldwide Key Players Into Human Biobanking Industry That Project Improved Market Activities In The Near Future




To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expe

Read More...
Choose License Type
Single User - US $4160
Multi User - US $5960
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify